Related Experiment Video
Updated: Aug 12, 2025

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
Opium may affect coronary artery disease by inducing inflammation but not through the expression of CD9, CD36, and
Mohammad Amin Momeni-Moghaddam1,2, Gholamreza Asadikaram2,3, Mohammad Masoumi4
1Department of Nutrition and Biochemistry, Gonabad University of Medical Sciences, Gonabad, Iran.
Abstract:
The molecular mechanisms of opium action with regard to coronary artery disease (CAD) have not yet been determined. The aim of this study was to evaluate the effect of opium on the expression of scavenger receptors including CD36, CD68, and CD9 tetraspanin in monocytes and the plasma levels of tumor necrosis factor alpha (TNF-α), interferon gamma (IFN-γ), malondialdehyde (MDA), and nitric oxide metabolites (NOx) in CAD patients with and without opium addiction. This case-control study was conducted on three groups: (1) opium-addicted CAD patients (CAD + OA, n = 30); (2) CAD patients with no opium addiction (CAD, n = 30); and (3) individuals without CAD and opium addiction as the control group (Ctrl, n = 17). The protein and mRNA levels of CD9, CD36, and CD68 were evaluated by the flow cytometry and quantitative polymerase chain reaction (RT-qPCR) methods, respectively. The consumption of atorvastatin, aspirin, and glyceryl trinitrate was found be higher in the CAD groups compared with the control group. The plasma level of TNF-α was significantly higher in the CAD + OA group than in the CAD and Ctrl groups (p = 0.001 and p = 0.005, respectively). MDA levels significantly increased in CAD and CAD + OA patients in comparison with the Ctrl group (p = 0.010 and p = 0.002, respectively). No significant differences were found in CD9, CD36, CD68, IFN-γ, and NOx between the three groups. The findings demonstrated that opium did not have a significant effect on the expression of CD36, CD68, and CD9 at gene and protein levels, but it might be involved in the development of CAD by inducing inflammation through other mechanisms.
Insights
Opium addiction did not alter scavenger receptor expression in coronary artery disease (CAD) patients. However, opium use was linked to increased inflammation via tumor necrosis factor-alpha (TNF-α) and malondialdehyde (MDA) in CAD.
Area of Science:
- Cardiovascular Science
- Pharmacology
- Immunology
Background:
- Coronary artery disease (CAD) mechanisms are complex and not fully understood.
- The impact of opium on CAD pathogenesis, particularly regarding inflammatory markers and scavenger receptors, requires investigation.
Purpose of the Study:
- To investigate the effect of opium addiction on scavenger receptor expression (CD36, CD68, CD9) in monocytes.
- To evaluate plasma levels of tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), malondialdehyde (MDA), and nitric oxide metabolites (NOx) in CAD patients with and without opium addiction.
Main Methods:
- Case-control study involving three groups: opium-addicted CAD patients, non-addicted CAD patients, and controls.
- Quantitative polymerase chain reaction (RT-qPCR) and flow cytometry used to assess gene and protein expression of CD9, CD36, and CD68.
- Plasma levels of TNF-α, IFN-γ, MDA, and NOx were measured.
Main Results:
- Opium-addicted CAD patients showed significantly higher plasma levels of TNF-α compared to both non-addicted CAD patients and controls.
- Malondialdehyde (MDA) levels were significantly elevated in both CAD groups versus controls.
- No significant differences were observed in the expression of CD9, CD36, CD68, IFN-γ, or NOx across the three groups.
Conclusions:
- Opium addiction does not appear to significantly affect the gene or protein expression of CD36, CD68, and CD9 in CAD patients.
- Opium may contribute to CAD development through inflammatory pathways independent of these specific scavenger receptors, evidenced by elevated TNF-α.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease I: Introduction
Opioid Receptors: Overview
Analgesia and Pain Management
Peripheral Artery Disease I: Introduction
Coronary Artery Disease III: Clinical Manifestations

